XML 19 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements
3 Months Ended
Mar. 29, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 3: Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including money market securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There were no transfers between fair value measurement levels during the three months ended March 29, 2024 and March 31, 2023. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. The fair value of these financial assets and liabilities was determined using the following inputs at March 29, 2024 (in thousands):

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Total

 

 

Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities (1)

 

$

55,402

 

 

$

55,402

 

 

$

-

 

 

$

-

 

Fixed income trading securities held in deferred
   compensation plan
(2)

 

 

44,669

 

 

 

44,669

 

 

 

-

 

 

 

-

 

Equity trading securities held in deferred compensation
   plan
(2)

 

 

83,466

 

 

$

83,466

 

 

 

-

 

 

 

-

 

Total

 

$

183,537

 

 

$

183,537

 

 

$

-

 

 

$

-

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Deferred compensation plan (3)

 

 

129,139

 

 

 

129,139

 

 

 

-

 

 

 

-

 

Total

 

$

129,139

 

 

$

129,139

 

 

$

-

 

 

$

-

 

(1) Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.

(2) Included in prepaid expenses and other current assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.

(3) Included in accrued payroll and employee benefits and deferred compensation plan liabilities on the Company’s unaudited condensed consolidated balance sheet.

The fair value of these certain financial assets and liabilities was determined using the following inputs at December 29, 2023 (in thousands):

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

Total

 

 

Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities (1)

 

$

54,686

 

 

$

54,686

 

 

$

-

 

 

$

-

 

Fixed income trading securities held in deferred
   compensation plan
(2)

 

 

36,788

 

 

 

36,788

 

 

 

-

 

 

 

-

 

Equity trading securities held in deferred compensation
   plan
(2)

 

 

78,399

 

 

 

78,399

 

 

 

-

 

 

 

-

 

Total

 

$

169,873

 

 

$

169,873

 

 

$

-

 

 

$

-

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Deferred compensation plan (3)

 

 

116,564

 

 

 

116,564

 

 

 

-

 

 

 

-

 

Total

 

$

116,564

 

 

$

116,564

 

 

$

-

 

 

$

-

 

(1) Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.

(2) Included in prepaid expenses and other current assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.

(3) Included in accrued payroll and employee benefits and deferred compensation plan liabilities on the Company’s unaudited condensed consolidated balance sheet.

Money market securities as of March 29, 2024 and December 29, 2023 represent obligations of the United States Treasury. Fixed income and equity trading securities represent mutual funds held in the Company’s deferred compensation plan. See Note 6 for additional information about the Company’s deferred compensation plan.

Cash and cash equivalents consisted of the following as of March 29, 2024 (in thousands):

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Classified as current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

113,263

 

 

$

-

 

 

$

-

 

 

$

113,263

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities

 

 

55,402

 

 

 

-

 

 

 

-

 

 

 

55,402

 

Total cash equivalents

 

 

55,402

 

 

 

-

 

 

 

-

 

 

 

55,402

 

Total cash and cash equivalents

 

$

168,665

 

 

$

-

 

 

$

-

 

 

$

168,665

 

 

 

Cash and cash equivalents consisted of the following as of December 29, 2023 (in thousands):

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Classified as current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

132,464

 

 

$

-

 

 

$

-

 

 

$

132,464

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market securities

 

 

54,686

 

 

 

-

 

 

 

-

 

 

 

54,686

 

Total cash equivalents

 

 

54,686

 

 

 

-

 

 

 

-

 

 

 

54,686

 

Total cash and cash equivalents

 

$

187,150

 

 

$

-

 

 

$

-

 

 

$

187,150

 

 

 

At March 29, 2024 and December 29, 2023, the Company did not have any assets or liabilities valued using significant unobservable inputs.

The following financial instruments are not measured at fair value on the Company's unaudited condensed consolidated balance sheet at March 29, 2024 and December 29, 2023, but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at March 29, 2024 and December 29, 2023 approximates their carrying value as reported on the Company’s unaudited condensed consolidated balance sheets.